Table 3.
Questionnairesa |
Before introduction of time out consultation (N = 72) Mean (SD; SE) |
After introduction of time out consultation (N = 98) Mean (SD; SE) |
p‐value |
---|---|---|---|
PAM‐13 (range 0–100, optimal score 100) | 71.93 (8.0; 0.9) | 74.02 (8.7; 0.8) | .113 |
PEPPI‐5 (range 0–100, optimal score 100) | 68.89 (13.6; 1.6) | 71.22 (12.9; 1.3) | .257 |
SDM‐Q‐9 (range 0–100, optimal score 100) | 52.87 (24.6; 2.9) | 53.51 (27.6; 2.7) | .875 |
DCS‐16 (range 0–100, optimal score 0) | 32.98 (19.1; 2.2) | 28.71 (15.7; 1.5) | .112 |
EORTC IN‐PATSAT‐32 (range 0–100, optimal score 100) | 56.71 (13.9; 1.6) | 59.90 (17.7; 1.7) | .208 |
DCS‐16 (Decisional Conflict Scale); EORTC IN‐PATSAT‐32 (Patient Satisfaction); PAM‐13 (Patient Activation Measurement); PEPPI‐5 (Perceived Efficacy in Patient–Physician Interactions); SDM‐Q‐9 (Shared Decision‐Making).